Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Nat Prod ; 72(8): 1459-64, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19650637

RESUMO

Seven new iridoid glucosides, 6''-O-trans-sinapoylgenipin gentiobioside (1), 6''-O-trans-p-coumaroylgenipin gentiobioside (2), 6''-O-trans-cinnamoylgenipin gentiobioside (3), 6'-O-trans-p-coumaroylgeniposide (4), 6'-O-trans-p-coumaroylgeniposidic acid (5), 10-O-succinoylgeniposide (6), and 6'-O-acetylgeniposide (7), two new monoterpenoids, 11-(6-O-trans-sinapoylglucopyranosyl)gardendiol (8) and 10-(6-O-trans-sinapoylglucopyranosyl)gardendiol (9), and three known ones, 6'-O-trans-sinapoylgeniposide (10), geniposide (11), and 10-O-acetylgeniposide (12), were isolated from the fruit of Gardenia jasminoides. The structures of these compounds were elucidated on the basis of 1D and 2D NMR spectra analyses. Furthermore, short-term memory assays on an Abeta transgenic drosophila model showed that compounds 4 and 6-12 can improve the short-term memory capacity to varying degrees, with compounds 4 and 7 being the most active ones, suggesting that these compounds may have a potential antagonism effect against Alzheimer's disease.


Assuntos
Gardenia/química , Iridoides/isolamento & purificação , Iridoides/farmacologia , Memória de Curto Prazo/efeitos dos fármacos , Doença de Alzheimer/tratamento farmacológico , Animais , Animais Geneticamente Modificados , Modelos Animais de Doenças , Drosophila , Frutas/química , Iridoides/química , Estrutura Molecular , Ressonância Magnética Nuclear Biomolecular , Estereoisomerismo
2.
Neurosci Lett ; 414(1): 57-60, 2007 Feb 27.
Artigo em Inglês | MEDLINE | ID: mdl-17223264

RESUMO

Kainic acid (KA) treatment is a well-established model of hippocampal neuron death mediated in large part by KA receptor-induced excitotoxicity. KA-induced, delayed neuron death has been shown previously to follow the induction of seizures and exhibit characteristics of both apoptosis and necrosis. Growing evidence supports a role of autophagic stress-induced death of neurons in several in vitro and in vivo models of neuron death and neurodegeneration. However, whether autophagic stress also plays a role in KA-induced excitotoxicity has not been previously investigated. To examine whether KA alters the levels of proteins associated with or known to regulate the formation of autophagic vacuoles, we isolated hippocampal extracts from control mice and in mice following 2-16 h KA injection. KA induced a significant increase in the amount of LC3-II, a specific marker of autophagic vacuoles, at 4-6h following KA, which indicates a transient induction of autophagic stress. Levels of autophagy-associated proteins including ATG5 (conjugated to ATG12), ATG6 and ATG7 did not change significantly after treatment with KA. However, ratios of phospho-mTOR/mTOR were elevated from 6 to 16 h, and ratios of phospho-Akt/Akt were elevated at 16 h following KA treatment, suggesting a potential negative feedback loop to inhibit further stimulation of autophagic stress. Together these data indicate the transient induction of autophagic stress by KA which may serve to regulate excitotoxic death in mouse hippocampus.


Assuntos
Autofagia/fisiologia , Epilepsia/metabolismo , Hipocampo/metabolismo , Degeneração Neural/metabolismo , Neurotoxinas/toxicidade , Estresse Fisiológico/metabolismo , Animais , Autofagia/efeitos dos fármacos , Proteína 5 Relacionada à Autofagia , Biomarcadores/análise , Biomarcadores/metabolismo , Epilepsia/induzido quimicamente , Epilepsia/fisiopatologia , Hipocampo/efeitos dos fármacos , Hipocampo/fisiopatologia , Ácido Caínico/toxicidade , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Proteínas Associadas aos Microtúbulos/efeitos dos fármacos , Proteínas Associadas aos Microtúbulos/metabolismo , Chaperonas Moleculares/efeitos dos fármacos , Chaperonas Moleculares/metabolismo , Degeneração Neural/induzido quimicamente , Degeneração Neural/fisiopatologia , Proteína Oncogênica v-akt/efeitos dos fármacos , Proteína Oncogênica v-akt/metabolismo , Estresse Fisiológico/induzido quimicamente , Estresse Fisiológico/fisiopatologia , Ubiquitinas/efeitos dos fármacos , Ubiquitinas/metabolismo , Regulação para Cima/efeitos dos fármacos , Regulação para Cima/fisiologia
3.
Fitoterapia ; 83(3): 563-7, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22245087

RESUMO

A new lignan glucoside, (+)-(7S,8R,8'R)-lyoniresinol 9-O-ß-D-(6″-O-trans-sinapoyl)glucopyranoside (1), and a new iridoid glucoside, 10-O-trans-sinapoylgeniposide (2), together with eight known compounds, were isolated from the fruits of Gardenia jasminoides Ellis. The structures of the isolates were elucidated by extensive spectroscopic studies, including UV, IR, 1D and 2D NMR, ESI-MS, HR-ESI-MS, and CD experiments. The short-term-memory-enhancement activities of some compounds were evaluated on an Aß transgenic drosophila model.


Assuntos
Frutas/química , Gardenia/química , Glicosídeos/isolamento & purificação , Iridoides/isolamento & purificação , Lignanas/isolamento & purificação , Memória de Curto Prazo/efeitos dos fármacos , Nootrópicos/isolamento & purificação , Extratos Vegetais/química , Doença de Alzheimer/tratamento farmacológico , Animais , Animais Geneticamente Modificados , Modelos Animais de Doenças , Drosophila , Glicosídeos/química , Glicosídeos/farmacologia , Humanos , Iridoides/química , Iridoides/farmacologia , Lignanas/química , Lignanas/farmacologia , Estrutura Molecular , Nootrópicos/farmacologia , Nootrópicos/uso terapêutico , Fitoterapia , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico
4.
Mol Brain ; 1: 17, 2008 Nov 21.
Artigo em Inglês | MEDLINE | ID: mdl-19021916

RESUMO

α-synuclein (α-syn) is a main component of Lewy bodies (LB) that occur in many neurodegenerative diseases, including Parkinson's disease (PD), dementia with LB (DLB) and multi-system atrophy. α-syn mutations or amplifications are responsible for a subset of autosomal dominant familial PD cases, and overexpression causes neurodegeneration and motor disturbances in animals. To investigate mechanisms for α-syn accumulation and toxicity, we studied a mouse model of lysosomal enzyme cathepsin D (CD) deficiency, and found extensive accumulation of endogenous α-syn in neurons without overabundance of α-syn mRNA. In addition to impaired macroautophagy, CD deficiency reduced proteasome activity, suggesting an essential role for lysosomal CD function in regulating multiple proteolytic pathways that are important for α-syn metabolism. Conversely, CD overexpression reduces α-syn aggregation and is neuroprotective against α-syn overexpression-induced cell death in vitro. In a C. elegans model, CD deficiency exacerbates α-syn accumulation while its overexpression is protective against α-syn-induced dopaminergic neurodegeneration. Mutated CD with diminished enzymatic activity or overexpression of cathepsins B (CB) or L (CL) is not protective in the worm model, indicating a unique requirement for enzymatically active CD. Our data identify a conserved CD function in α-syn degradation and identify CD as a novel target for LB disease therapeutics.


Assuntos
Catepsina D/metabolismo , Lisossomos/enzimologia , alfa-Sinucleína/metabolismo , alfa-Sinucleína/toxicidade , Animais , Caenorhabditis elegans/efeitos dos fármacos , Caspase 3/metabolismo , Catepsina D/deficiência , Linhagem Celular Tumoral , Humanos , Lisossomos/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Fármacos Neuroprotetores/metabolismo , Fagossomos/efeitos dos fármacos , Fagossomos/metabolismo , Mutação Puntual/genética , Complexo de Endopeptidases do Proteassoma/metabolismo , Estrutura Quaternária de Proteína , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Regulação para Cima/efeitos dos fármacos , Regulação para Cima/genética , alfa-Sinucleína/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA